Global Immuno-oncology Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Immuno-oncology Therapy market size was valued at USD 1268.7 million in 2023 and is forecast to a readjusted size of USD 1704.3 million by 2030 with a CAGR of 4.3% during review period.
Immuno-oncology therapy is a type of cancer treatment that harnesses the body's immune system to target and destroy cancer cells. It includes therapies such as immune checkpoint inhibitors, cancer vaccines, and adoptive T cell therapies.
The market for immuno-oncology therapy is driven by the growing interest in personalized and targeted cancer treatments and the need for innovative therapies with fewer side effects. The market's growth is also influenced by the approval of new immuno-oncology drugs and ongoing research in cancer immunotherapy.
The Global Info Research report includes an overview of the development of the Immuno-oncology Therapy industry chain, the market status of Hospitals (Monoclonal Antibodies, Immune Checkpoint Inhibitors), Ambulatory Surgical Center (Monoclonal Antibodies, Immune Checkpoint Inhibitors), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Immuno-oncology Therapy.
Regionally, the report analyzes the Immuno-oncology Therapy markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Immuno-oncology Therapy market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Immuno-oncology Therapy market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Immuno-oncology Therapy industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Monoclonal Antibodies, Immune Checkpoint Inhibitors).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Immuno-oncology Therapy market.
Regional Analysis: The report involves examining the Immuno-oncology Therapy market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Immuno-oncology Therapy market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Immuno-oncology Therapy:
Company Analysis: Report covers individual Immuno-oncology Therapy players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Immuno-oncology Therapy This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Ambulatory Surgical Center).
Technology Analysis: Report covers specific technologies relevant to Immuno-oncology Therapy. It assesses the current state, advancements, and potential future developments in Immuno-oncology Therapy areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Immuno-oncology Therapy market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Immuno-oncology Therapy market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Chapter 1, to describe Immuno-oncology Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Immuno-oncology Therapy, with revenue, gross margin and global market share of Immuno-oncology Therapy from 2019 to 2024.
Chapter 3, the Immuno-oncology Therapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Immuno-oncology Therapy market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Immuno-oncology Therapy.
Chapter 13, to describe Immuno-oncology Therapy research findings and conclusion.
Immuno-oncology therapy is a type of cancer treatment that harnesses the body's immune system to target and destroy cancer cells. It includes therapies such as immune checkpoint inhibitors, cancer vaccines, and adoptive T cell therapies.
The market for immuno-oncology therapy is driven by the growing interest in personalized and targeted cancer treatments and the need for innovative therapies with fewer side effects. The market's growth is also influenced by the approval of new immuno-oncology drugs and ongoing research in cancer immunotherapy.
The Global Info Research report includes an overview of the development of the Immuno-oncology Therapy industry chain, the market status of Hospitals (Monoclonal Antibodies, Immune Checkpoint Inhibitors), Ambulatory Surgical Center (Monoclonal Antibodies, Immune Checkpoint Inhibitors), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Immuno-oncology Therapy.
Regionally, the report analyzes the Immuno-oncology Therapy markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Immuno-oncology Therapy market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Immuno-oncology Therapy market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Immuno-oncology Therapy industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Monoclonal Antibodies, Immune Checkpoint Inhibitors).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Immuno-oncology Therapy market.
Regional Analysis: The report involves examining the Immuno-oncology Therapy market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Immuno-oncology Therapy market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Immuno-oncology Therapy:
Company Analysis: Report covers individual Immuno-oncology Therapy players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Immuno-oncology Therapy This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Ambulatory Surgical Center).
Technology Analysis: Report covers specific technologies relevant to Immuno-oncology Therapy. It assesses the current state, advancements, and potential future developments in Immuno-oncology Therapy areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Immuno-oncology Therapy market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Immuno-oncology Therapy market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- Monoclonal Antibodies
- Immune Checkpoint Inhibitors
- Immune System Modulators
- Cancer Vaccines
- Hospitals
- Ambulatory Surgical Center
- Others
- Amgen
- AstraZeneca
- Bristol-Myers Squibb
- Eli-Lilly
- Roche
- GlaxoSmithKline
- Janssen Biotech
- Merck
- Novartis
- Pfizer
- Sanofi
- Spectrum Pharmaceuticals
- Takeda
- BioNTech SE
- Allogene Therapeutics
- IMAB-I-Mab Biopharma Co., Ltd.
- Arcus Biosciences
- Gritstone Oncology
- Autolus Therapeutics
- Rubius Therapeutics
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Immuno-oncology Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Immuno-oncology Therapy, with revenue, gross margin and global market share of Immuno-oncology Therapy from 2019 to 2024.
Chapter 3, the Immuno-oncology Therapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Immuno-oncology Therapy market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Immuno-oncology Therapy.
Chapter 13, to describe Immuno-oncology Therapy research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Immuno-oncology Therapy
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Immuno-oncology Therapy by Type
1.3.1 Overview: Global Immuno-oncology Therapy Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Immuno-oncology Therapy Consumption Value Market Share by Type in 2023
1.3.3 Monoclonal Antibodies
1.3.4 Immune Checkpoint Inhibitors
1.3.5 Immune System Modulators
1.3.6 Cancer Vaccines
1.4 Global Immuno-oncology Therapy Market by Application
1.4.1 Overview: Global Immuno-oncology Therapy Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospitals
1.4.3 Ambulatory Surgical Center
1.4.4 Others
1.5 Global Immuno-oncology Therapy Market Size & Forecast
1.6 Global Immuno-oncology Therapy Market Size and Forecast by Region
1.6.1 Global Immuno-oncology Therapy Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Immuno-oncology Therapy Market Size by Region, (2019-2030)
1.6.3 North America Immuno-oncology Therapy Market Size and Prospect (2019-2030)
1.6.4 Europe Immuno-oncology Therapy Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Immuno-oncology Therapy Market Size and Prospect (2019-2030)
1.6.6 South America Immuno-oncology Therapy Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Immuno-oncology Therapy Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Amgen
2.1.1 Amgen Details
2.1.2 Amgen Major Business
2.1.3 Amgen Immuno-oncology Therapy Product and Solutions
2.1.4 Amgen Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Amgen Recent Developments and Future Plans
2.2 AstraZeneca
2.2.1 AstraZeneca Details
2.2.2 AstraZeneca Major Business
2.2.3 AstraZeneca Immuno-oncology Therapy Product and Solutions
2.2.4 AstraZeneca Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 AstraZeneca Recent Developments and Future Plans
2.3 Bristol-Myers Squibb
2.3.1 Bristol-Myers Squibb Details
2.3.2 Bristol-Myers Squibb Major Business
2.3.3 Bristol-Myers Squibb Immuno-oncology Therapy Product and Solutions
2.3.4 Bristol-Myers Squibb Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Bristol-Myers Squibb Recent Developments and Future Plans
2.4 Eli-Lilly
2.4.1 Eli-Lilly Details
2.4.2 Eli-Lilly Major Business
2.4.3 Eli-Lilly Immuno-oncology Therapy Product and Solutions
2.4.4 Eli-Lilly Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Eli-Lilly Recent Developments and Future Plans
2.5 Roche
2.5.1 Roche Details
2.5.2 Roche Major Business
2.5.3 Roche Immuno-oncology Therapy Product and Solutions
2.5.4 Roche Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Roche Recent Developments and Future Plans
2.6 GlaxoSmithKline
2.6.1 GlaxoSmithKline Details
2.6.2 GlaxoSmithKline Major Business
2.6.3 GlaxoSmithKline Immuno-oncology Therapy Product and Solutions
2.6.4 GlaxoSmithKline Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 GlaxoSmithKline Recent Developments and Future Plans
2.7 Janssen Biotech
2.7.1 Janssen Biotech Details
2.7.2 Janssen Biotech Major Business
2.7.3 Janssen Biotech Immuno-oncology Therapy Product and Solutions
2.7.4 Janssen Biotech Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Janssen Biotech Recent Developments and Future Plans
2.8 Merck
2.8.1 Merck Details
2.8.2 Merck Major Business
2.8.3 Merck Immuno-oncology Therapy Product and Solutions
2.8.4 Merck Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Merck Recent Developments and Future Plans
2.9 Novartis
2.9.1 Novartis Details
2.9.2 Novartis Major Business
2.9.3 Novartis Immuno-oncology Therapy Product and Solutions
2.9.4 Novartis Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Novartis Recent Developments and Future Plans
2.10 Pfizer
2.10.1 Pfizer Details
2.10.2 Pfizer Major Business
2.10.3 Pfizer Immuno-oncology Therapy Product and Solutions
2.10.4 Pfizer Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Pfizer Recent Developments and Future Plans
2.11 Sanofi
2.11.1 Sanofi Details
2.11.2 Sanofi Major Business
2.11.3 Sanofi Immuno-oncology Therapy Product and Solutions
2.11.4 Sanofi Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Sanofi Recent Developments and Future Plans
2.12 Spectrum Pharmaceuticals
2.12.1 Spectrum Pharmaceuticals Details
2.12.2 Spectrum Pharmaceuticals Major Business
2.12.3 Spectrum Pharmaceuticals Immuno-oncology Therapy Product and Solutions
2.12.4 Spectrum Pharmaceuticals Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Spectrum Pharmaceuticals Recent Developments and Future Plans
2.13 Takeda
2.13.1 Takeda Details
2.13.2 Takeda Major Business
2.13.3 Takeda Immuno-oncology Therapy Product and Solutions
2.13.4 Takeda Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Takeda Recent Developments and Future Plans
2.14 BioNTech SE
2.14.1 BioNTech SE Details
2.14.2 BioNTech SE Major Business
2.14.3 BioNTech SE Immuno-oncology Therapy Product and Solutions
2.14.4 BioNTech SE Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 BioNTech SE Recent Developments and Future Plans
2.15 Allogene Therapeutics
2.15.1 Allogene Therapeutics Details
2.15.2 Allogene Therapeutics Major Business
2.15.3 Allogene Therapeutics Immuno-oncology Therapy Product and Solutions
2.15.4 Allogene Therapeutics Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Allogene Therapeutics Recent Developments and Future Plans
2.16 IMAB-I-Mab Biopharma Co., Ltd.
2.16.1 IMAB-I-Mab Biopharma Co., Ltd. Details
2.16.2 IMAB-I-Mab Biopharma Co., Ltd. Major Business
2.16.3 IMAB-I-Mab Biopharma Co., Ltd. Immuno-oncology Therapy Product and Solutions
2.16.4 IMAB-I-Mab Biopharma Co., Ltd. Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 IMAB-I-Mab Biopharma Co., Ltd. Recent Developments and Future Plans
2.17 Arcus Biosciences
2.17.1 Arcus Biosciences Details
2.17.2 Arcus Biosciences Major Business
2.17.3 Arcus Biosciences Immuno-oncology Therapy Product and Solutions
2.17.4 Arcus Biosciences Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 Arcus Biosciences Recent Developments and Future Plans
2.18 Gritstone Oncology
2.18.1 Gritstone Oncology Details
2.18.2 Gritstone Oncology Major Business
2.18.3 Gritstone Oncology Immuno-oncology Therapy Product and Solutions
2.18.4 Gritstone Oncology Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.18.5 Gritstone Oncology Recent Developments and Future Plans
2.19 Autolus Therapeutics
2.19.1 Autolus Therapeutics Details
2.19.2 Autolus Therapeutics Major Business
2.19.3 Autolus Therapeutics Immuno-oncology Therapy Product and Solutions
2.19.4 Autolus Therapeutics Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.19.5 Autolus Therapeutics Recent Developments and Future Plans
2.20 Rubius Therapeutics
2.20.1 Rubius Therapeutics Details
2.20.2 Rubius Therapeutics Major Business
2.20.3 Rubius Therapeutics Immuno-oncology Therapy Product and Solutions
2.20.4 Rubius Therapeutics Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.20.5 Rubius Therapeutics Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Immuno-oncology Therapy Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Immuno-oncology Therapy by Company Revenue
3.2.2 Top 3 Immuno-oncology Therapy Players Market Share in 2023
3.2.3 Top 6 Immuno-oncology Therapy Players Market Share in 2023
3.3 Immuno-oncology Therapy Market: Overall Company Footprint Analysis
3.3.1 Immuno-oncology Therapy Market: Region Footprint
3.3.2 Immuno-oncology Therapy Market: Company Product Type Footprint
3.3.3 Immuno-oncology Therapy Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Immuno-oncology Therapy Consumption Value and Market Share by Type (2019-2024)
4.2 Global Immuno-oncology Therapy Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Immuno-oncology Therapy Consumption Value Market Share by Application (2019-2024)
5.2 Global Immuno-oncology Therapy Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Immuno-oncology Therapy Consumption Value by Type (2019-2030)
6.2 North America Immuno-oncology Therapy Consumption Value by Application (2019-2030)
6.3 North America Immuno-oncology Therapy Market Size by Country
6.3.1 North America Immuno-oncology Therapy Consumption Value by Country (2019-2030)
6.3.2 United States Immuno-oncology Therapy Market Size and Forecast (2019-2030)
6.3.3 Canada Immuno-oncology Therapy Market Size and Forecast (2019-2030)
6.3.4 Mexico Immuno-oncology Therapy Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Immuno-oncology Therapy Consumption Value by Type (2019-2030)
7.2 Europe Immuno-oncology Therapy Consumption Value by Application (2019-2030)
7.3 Europe Immuno-oncology Therapy Market Size by Country
7.3.1 Europe Immuno-oncology Therapy Consumption Value by Country (2019-2030)
7.3.2 Germany Immuno-oncology Therapy Market Size and Forecast (2019-2030)
7.3.3 France Immuno-oncology Therapy Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Immuno-oncology Therapy Market Size and Forecast (2019-2030)
7.3.5 Russia Immuno-oncology Therapy Market Size and Forecast (2019-2030)
7.3.6 Italy Immuno-oncology Therapy Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Immuno-oncology Therapy Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Immuno-oncology Therapy Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Immuno-oncology Therapy Market Size by Region
8.3.1 Asia-Pacific Immuno-oncology Therapy Consumption Value by Region (2019-2030)
8.3.2 China Immuno-oncology Therapy Market Size and Forecast (2019-2030)
8.3.3 Japan Immuno-oncology Therapy Market Size and Forecast (2019-2030)
8.3.4 South Korea Immuno-oncology Therapy Market Size and Forecast (2019-2030)
8.3.5 India Immuno-oncology Therapy Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Immuno-oncology Therapy Market Size and Forecast (2019-2030)
8.3.7 Australia Immuno-oncology Therapy Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Immuno-oncology Therapy Consumption Value by Type (2019-2030)
9.2 South America Immuno-oncology Therapy Consumption Value by Application (2019-2030)
9.3 South America Immuno-oncology Therapy Market Size by Country
9.3.1 South America Immuno-oncology Therapy Consumption Value by Country (2019-2030)
9.3.2 Brazil Immuno-oncology Therapy Market Size and Forecast (2019-2030)
9.3.3 Argentina Immuno-oncology Therapy Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Immuno-oncology Therapy Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Immuno-oncology Therapy Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Immuno-oncology Therapy Market Size by Country
10.3.1 Middle East & Africa Immuno-oncology Therapy Consumption Value by Country (2019-2030)
10.3.2 Turkey Immuno-oncology Therapy Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Immuno-oncology Therapy Market Size and Forecast (2019-2030)
10.3.4 UAE Immuno-oncology Therapy Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Immuno-oncology Therapy Market Drivers
11.2 Immuno-oncology Therapy Market Restraints
11.3 Immuno-oncology Therapy Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Immuno-oncology Therapy Industry Chain
12.2 Immuno-oncology Therapy Upstream Analysis
12.3 Immuno-oncology Therapy Midstream Analysis
12.4 Immuno-oncology Therapy Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Immuno-oncology Therapy
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Immuno-oncology Therapy by Type
1.3.1 Overview: Global Immuno-oncology Therapy Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Immuno-oncology Therapy Consumption Value Market Share by Type in 2023
1.3.3 Monoclonal Antibodies
1.3.4 Immune Checkpoint Inhibitors
1.3.5 Immune System Modulators
1.3.6 Cancer Vaccines
1.4 Global Immuno-oncology Therapy Market by Application
1.4.1 Overview: Global Immuno-oncology Therapy Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospitals
1.4.3 Ambulatory Surgical Center
1.4.4 Others
1.5 Global Immuno-oncology Therapy Market Size & Forecast
1.6 Global Immuno-oncology Therapy Market Size and Forecast by Region
1.6.1 Global Immuno-oncology Therapy Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Immuno-oncology Therapy Market Size by Region, (2019-2030)
1.6.3 North America Immuno-oncology Therapy Market Size and Prospect (2019-2030)
1.6.4 Europe Immuno-oncology Therapy Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Immuno-oncology Therapy Market Size and Prospect (2019-2030)
1.6.6 South America Immuno-oncology Therapy Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Immuno-oncology Therapy Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Amgen
2.1.1 Amgen Details
2.1.2 Amgen Major Business
2.1.3 Amgen Immuno-oncology Therapy Product and Solutions
2.1.4 Amgen Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Amgen Recent Developments and Future Plans
2.2 AstraZeneca
2.2.1 AstraZeneca Details
2.2.2 AstraZeneca Major Business
2.2.3 AstraZeneca Immuno-oncology Therapy Product and Solutions
2.2.4 AstraZeneca Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 AstraZeneca Recent Developments and Future Plans
2.3 Bristol-Myers Squibb
2.3.1 Bristol-Myers Squibb Details
2.3.2 Bristol-Myers Squibb Major Business
2.3.3 Bristol-Myers Squibb Immuno-oncology Therapy Product and Solutions
2.3.4 Bristol-Myers Squibb Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Bristol-Myers Squibb Recent Developments and Future Plans
2.4 Eli-Lilly
2.4.1 Eli-Lilly Details
2.4.2 Eli-Lilly Major Business
2.4.3 Eli-Lilly Immuno-oncology Therapy Product and Solutions
2.4.4 Eli-Lilly Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Eli-Lilly Recent Developments and Future Plans
2.5 Roche
2.5.1 Roche Details
2.5.2 Roche Major Business
2.5.3 Roche Immuno-oncology Therapy Product and Solutions
2.5.4 Roche Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Roche Recent Developments and Future Plans
2.6 GlaxoSmithKline
2.6.1 GlaxoSmithKline Details
2.6.2 GlaxoSmithKline Major Business
2.6.3 GlaxoSmithKline Immuno-oncology Therapy Product and Solutions
2.6.4 GlaxoSmithKline Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 GlaxoSmithKline Recent Developments and Future Plans
2.7 Janssen Biotech
2.7.1 Janssen Biotech Details
2.7.2 Janssen Biotech Major Business
2.7.3 Janssen Biotech Immuno-oncology Therapy Product and Solutions
2.7.4 Janssen Biotech Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Janssen Biotech Recent Developments and Future Plans
2.8 Merck
2.8.1 Merck Details
2.8.2 Merck Major Business
2.8.3 Merck Immuno-oncology Therapy Product and Solutions
2.8.4 Merck Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Merck Recent Developments and Future Plans
2.9 Novartis
2.9.1 Novartis Details
2.9.2 Novartis Major Business
2.9.3 Novartis Immuno-oncology Therapy Product and Solutions
2.9.4 Novartis Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Novartis Recent Developments and Future Plans
2.10 Pfizer
2.10.1 Pfizer Details
2.10.2 Pfizer Major Business
2.10.3 Pfizer Immuno-oncology Therapy Product and Solutions
2.10.4 Pfizer Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Pfizer Recent Developments and Future Plans
2.11 Sanofi
2.11.1 Sanofi Details
2.11.2 Sanofi Major Business
2.11.3 Sanofi Immuno-oncology Therapy Product and Solutions
2.11.4 Sanofi Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Sanofi Recent Developments and Future Plans
2.12 Spectrum Pharmaceuticals
2.12.1 Spectrum Pharmaceuticals Details
2.12.2 Spectrum Pharmaceuticals Major Business
2.12.3 Spectrum Pharmaceuticals Immuno-oncology Therapy Product and Solutions
2.12.4 Spectrum Pharmaceuticals Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Spectrum Pharmaceuticals Recent Developments and Future Plans
2.13 Takeda
2.13.1 Takeda Details
2.13.2 Takeda Major Business
2.13.3 Takeda Immuno-oncology Therapy Product and Solutions
2.13.4 Takeda Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Takeda Recent Developments and Future Plans
2.14 BioNTech SE
2.14.1 BioNTech SE Details
2.14.2 BioNTech SE Major Business
2.14.3 BioNTech SE Immuno-oncology Therapy Product and Solutions
2.14.4 BioNTech SE Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 BioNTech SE Recent Developments and Future Plans
2.15 Allogene Therapeutics
2.15.1 Allogene Therapeutics Details
2.15.2 Allogene Therapeutics Major Business
2.15.3 Allogene Therapeutics Immuno-oncology Therapy Product and Solutions
2.15.4 Allogene Therapeutics Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Allogene Therapeutics Recent Developments and Future Plans
2.16 IMAB-I-Mab Biopharma Co., Ltd.
2.16.1 IMAB-I-Mab Biopharma Co., Ltd. Details
2.16.2 IMAB-I-Mab Biopharma Co., Ltd. Major Business
2.16.3 IMAB-I-Mab Biopharma Co., Ltd. Immuno-oncology Therapy Product and Solutions
2.16.4 IMAB-I-Mab Biopharma Co., Ltd. Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 IMAB-I-Mab Biopharma Co., Ltd. Recent Developments and Future Plans
2.17 Arcus Biosciences
2.17.1 Arcus Biosciences Details
2.17.2 Arcus Biosciences Major Business
2.17.3 Arcus Biosciences Immuno-oncology Therapy Product and Solutions
2.17.4 Arcus Biosciences Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 Arcus Biosciences Recent Developments and Future Plans
2.18 Gritstone Oncology
2.18.1 Gritstone Oncology Details
2.18.2 Gritstone Oncology Major Business
2.18.3 Gritstone Oncology Immuno-oncology Therapy Product and Solutions
2.18.4 Gritstone Oncology Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.18.5 Gritstone Oncology Recent Developments and Future Plans
2.19 Autolus Therapeutics
2.19.1 Autolus Therapeutics Details
2.19.2 Autolus Therapeutics Major Business
2.19.3 Autolus Therapeutics Immuno-oncology Therapy Product and Solutions
2.19.4 Autolus Therapeutics Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.19.5 Autolus Therapeutics Recent Developments and Future Plans
2.20 Rubius Therapeutics
2.20.1 Rubius Therapeutics Details
2.20.2 Rubius Therapeutics Major Business
2.20.3 Rubius Therapeutics Immuno-oncology Therapy Product and Solutions
2.20.4 Rubius Therapeutics Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.20.5 Rubius Therapeutics Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Immuno-oncology Therapy Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Immuno-oncology Therapy by Company Revenue
3.2.2 Top 3 Immuno-oncology Therapy Players Market Share in 2023
3.2.3 Top 6 Immuno-oncology Therapy Players Market Share in 2023
3.3 Immuno-oncology Therapy Market: Overall Company Footprint Analysis
3.3.1 Immuno-oncology Therapy Market: Region Footprint
3.3.2 Immuno-oncology Therapy Market: Company Product Type Footprint
3.3.3 Immuno-oncology Therapy Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Immuno-oncology Therapy Consumption Value and Market Share by Type (2019-2024)
4.2 Global Immuno-oncology Therapy Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Immuno-oncology Therapy Consumption Value Market Share by Application (2019-2024)
5.2 Global Immuno-oncology Therapy Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Immuno-oncology Therapy Consumption Value by Type (2019-2030)
6.2 North America Immuno-oncology Therapy Consumption Value by Application (2019-2030)
6.3 North America Immuno-oncology Therapy Market Size by Country
6.3.1 North America Immuno-oncology Therapy Consumption Value by Country (2019-2030)
6.3.2 United States Immuno-oncology Therapy Market Size and Forecast (2019-2030)
6.3.3 Canada Immuno-oncology Therapy Market Size and Forecast (2019-2030)
6.3.4 Mexico Immuno-oncology Therapy Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Immuno-oncology Therapy Consumption Value by Type (2019-2030)
7.2 Europe Immuno-oncology Therapy Consumption Value by Application (2019-2030)
7.3 Europe Immuno-oncology Therapy Market Size by Country
7.3.1 Europe Immuno-oncology Therapy Consumption Value by Country (2019-2030)
7.3.2 Germany Immuno-oncology Therapy Market Size and Forecast (2019-2030)
7.3.3 France Immuno-oncology Therapy Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Immuno-oncology Therapy Market Size and Forecast (2019-2030)
7.3.5 Russia Immuno-oncology Therapy Market Size and Forecast (2019-2030)
7.3.6 Italy Immuno-oncology Therapy Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Immuno-oncology Therapy Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Immuno-oncology Therapy Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Immuno-oncology Therapy Market Size by Region
8.3.1 Asia-Pacific Immuno-oncology Therapy Consumption Value by Region (2019-2030)
8.3.2 China Immuno-oncology Therapy Market Size and Forecast (2019-2030)
8.3.3 Japan Immuno-oncology Therapy Market Size and Forecast (2019-2030)
8.3.4 South Korea Immuno-oncology Therapy Market Size and Forecast (2019-2030)
8.3.5 India Immuno-oncology Therapy Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Immuno-oncology Therapy Market Size and Forecast (2019-2030)
8.3.7 Australia Immuno-oncology Therapy Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Immuno-oncology Therapy Consumption Value by Type (2019-2030)
9.2 South America Immuno-oncology Therapy Consumption Value by Application (2019-2030)
9.3 South America Immuno-oncology Therapy Market Size by Country
9.3.1 South America Immuno-oncology Therapy Consumption Value by Country (2019-2030)
9.3.2 Brazil Immuno-oncology Therapy Market Size and Forecast (2019-2030)
9.3.3 Argentina Immuno-oncology Therapy Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Immuno-oncology Therapy Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Immuno-oncology Therapy Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Immuno-oncology Therapy Market Size by Country
10.3.1 Middle East & Africa Immuno-oncology Therapy Consumption Value by Country (2019-2030)
10.3.2 Turkey Immuno-oncology Therapy Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Immuno-oncology Therapy Market Size and Forecast (2019-2030)
10.3.4 UAE Immuno-oncology Therapy Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Immuno-oncology Therapy Market Drivers
11.2 Immuno-oncology Therapy Market Restraints
11.3 Immuno-oncology Therapy Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Immuno-oncology Therapy Industry Chain
12.2 Immuno-oncology Therapy Upstream Analysis
12.3 Immuno-oncology Therapy Midstream Analysis
12.4 Immuno-oncology Therapy Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Immuno-oncology Therapy Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Immuno-oncology Therapy Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Immuno-oncology Therapy Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Immuno-oncology Therapy Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Amgen Company Information, Head Office, and Major Competitors
Table 6. Amgen Major Business
Table 7. Amgen Immuno-oncology Therapy Product and Solutions
Table 8. Amgen Immuno-oncology Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Amgen Recent Developments and Future Plans
Table 10. AstraZeneca Company Information, Head Office, and Major Competitors
Table 11. AstraZeneca Major Business
Table 12. AstraZeneca Immuno-oncology Therapy Product and Solutions
Table 13. AstraZeneca Immuno-oncology Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. AstraZeneca Recent Developments and Future Plans
Table 15. Bristol-Myers Squibb Company Information, Head Office, and Major Competitors
Table 16. Bristol-Myers Squibb Major Business
Table 17. Bristol-Myers Squibb Immuno-oncology Therapy Product and Solutions
Table 18. Bristol-Myers Squibb Immuno-oncology Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Bristol-Myers Squibb Recent Developments and Future Plans
Table 20. Eli-Lilly Company Information, Head Office, and Major Competitors
Table 21. Eli-Lilly Major Business
Table 22. Eli-Lilly Immuno-oncology Therapy Product and Solutions
Table 23. Eli-Lilly Immuno-oncology Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Eli-Lilly Recent Developments and Future Plans
Table 25. Roche Company Information, Head Office, and Major Competitors
Table 26. Roche Major Business
Table 27. Roche Immuno-oncology Therapy Product and Solutions
Table 28. Roche Immuno-oncology Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Roche Recent Developments and Future Plans
Table 30. GlaxoSmithKline Company Information, Head Office, and Major Competitors
Table 31. GlaxoSmithKline Major Business
Table 32. GlaxoSmithKline Immuno-oncology Therapy Product and Solutions
Table 33. GlaxoSmithKline Immuno-oncology Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. GlaxoSmithKline Recent Developments and Future Plans
Table 35. Janssen Biotech Company Information, Head Office, and Major Competitors
Table 36. Janssen Biotech Major Business
Table 37. Janssen Biotech Immuno-oncology Therapy Product and Solutions
Table 38. Janssen Biotech Immuno-oncology Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Janssen Biotech Recent Developments and Future Plans
Table 40. Merck Company Information, Head Office, and Major Competitors
Table 41. Merck Major Business
Table 42. Merck Immuno-oncology Therapy Product and Solutions
Table 43. Merck Immuno-oncology Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Merck Recent Developments and Future Plans
Table 45. Novartis Company Information, Head Office, and Major Competitors
Table 46. Novartis Major Business
Table 47. Novartis Immuno-oncology Therapy Product and Solutions
Table 48. Novartis Immuno-oncology Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Novartis Recent Developments and Future Plans
Table 50. Pfizer Company Information, Head Office, and Major Competitors
Table 51. Pfizer Major Business
Table 52. Pfizer Immuno-oncology Therapy Product and Solutions
Table 53. Pfizer Immuno-oncology Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Pfizer Recent Developments and Future Plans
Table 55. Sanofi Company Information, Head Office, and Major Competitors
Table 56. Sanofi Major Business
Table 57. Sanofi Immuno-oncology Therapy Product and Solutions
Table 58. Sanofi Immuno-oncology Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. Sanofi Recent Developments and Future Plans
Table 60. Spectrum Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 61. Spectrum Pharmaceuticals Major Business
Table 62. Spectrum Pharmaceuticals Immuno-oncology Therapy Product and Solutions
Table 63. Spectrum Pharmaceuticals Immuno-oncology Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. Spectrum Pharmaceuticals Recent Developments and Future Plans
Table 65. Takeda Company Information, Head Office, and Major Competitors
Table 66. Takeda Major Business
Table 67. Takeda Immuno-oncology Therapy Product and Solutions
Table 68. Takeda Immuno-oncology Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. Takeda Recent Developments and Future Plans
Table 70. BioNTech SE Company Information, Head Office, and Major Competitors
Table 71. BioNTech SE Major Business
Table 72. BioNTech SE Immuno-oncology Therapy Product and Solutions
Table 73. BioNTech SE Immuno-oncology Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 74. BioNTech SE Recent Developments and Future Plans
Table 75. Allogene Therapeutics Company Information, Head Office, and Major Competitors
Table 76. Allogene Therapeutics Major Business
Table 77. Allogene Therapeutics Immuno-oncology Therapy Product and Solutions
Table 78. Allogene Therapeutics Immuno-oncology Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 79. Allogene Therapeutics Recent Developments and Future Plans
Table 80. IMAB-I-Mab Biopharma Co., Ltd. Company Information, Head Office, and Major Competitors
Table 81. IMAB-I-Mab Biopharma Co., Ltd. Major Business
Table 82. IMAB-I-Mab Biopharma Co., Ltd. Immuno-oncology Therapy Product and Solutions
Table 83. IMAB-I-Mab Biopharma Co., Ltd. Immuno-oncology Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 84. IMAB-I-Mab Biopharma Co., Ltd. Recent Developments and Future Plans
Table 85. Arcus Biosciences Company Information, Head Office, and Major Competitors
Table 86. Arcus Biosciences Major Business
Table 87. Arcus Biosciences Immuno-oncology Therapy Product and Solutions
Table 88. Arcus Biosciences Immuno-oncology Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Arcus Biosciences Recent Developments and Future Plans
Table 90. Gritstone Oncology Company Information, Head Office, and Major Competitors
Table 91. Gritstone Oncology Major Business
Table 92. Gritstone Oncology Immuno-oncology Therapy Product and Solutions
Table 93. Gritstone Oncology Immuno-oncology Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 94. Gritstone Oncology Recent Developments and Future Plans
Table 95. Autolus Therapeutics Company Information, Head Office, and Major Competitors
Table 96. Autolus Therapeutics Major Business
Table 97. Autolus Therapeutics Immuno-oncology Therapy Product and Solutions
Table 98. Autolus Therapeutics Immuno-oncology Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 99. Autolus Therapeutics Recent Developments and Future Plans
Table 100. Rubius Therapeutics Company Information, Head Office, and Major Competitors
Table 101. Rubius Therapeutics Major Business
Table 102. Rubius Therapeutics Immuno-oncology Therapy Product and Solutions
Table 103. Rubius Therapeutics Immuno-oncology Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 104. Rubius Therapeutics Recent Developments and Future Plans
Table 105. Global Immuno-oncology Therapy Revenue (USD Million) by Players (2019-2024)
Table 106. Global Immuno-oncology Therapy Revenue Share by Players (2019-2024)
Table 107. Breakdown of Immuno-oncology Therapy by Company Type (Tier 1, Tier 2, and Tier 3)
Table 108. Market Position of Players in Immuno-oncology Therapy, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 109. Head Office of Key Immuno-oncology Therapy Players
Table 110. Immuno-oncology Therapy Market: Company Product Type Footprint
Table 111. Immuno-oncology Therapy Market: Company Product Application Footprint
Table 112. Immuno-oncology Therapy New Market Entrants and Barriers to Market Entry
Table 113. Immuno-oncology Therapy Mergers, Acquisition, Agreements, and Collaborations
Table 114. Global Immuno-oncology Therapy Consumption Value (USD Million) by Type (2019-2024)
Table 115. Global Immuno-oncology Therapy Consumption Value Share by Type (2019-2024)
Table 116. Global Immuno-oncology Therapy Consumption Value Forecast by Type (2025-2030)
Table 117. Global Immuno-oncology Therapy Consumption Value by Application (2019-2024)
Table 118. Global Immuno-oncology Therapy Consumption Value Forecast by Application (2025-2030)
Table 119. North America Immuno-oncology Therapy Consumption Value by Type (2019-2024) & (USD Million)
Table 120. North America Immuno-oncology Therapy Consumption Value by Type (2025-2030) & (USD Million)
Table 121. North America Immuno-oncology Therapy Consumption Value by Application (2019-2024) & (USD Million)
Table 122. North America Immuno-oncology Therapy Consumption Value by Application (2025-2030) & (USD Million)
Table 123. North America Immuno-oncology Therapy Consumption Value by Country (2019-2024) & (USD Million)
Table 124. North America Immuno-oncology Therapy Consumption Value by Country (2025-2030) & (USD Million)
Table 125. Europe Immuno-oncology Therapy Consumption Value by Type (2019-2024) & (USD Million)
Table 126. Europe Immuno-oncology Therapy Consumption Value by Type (2025-2030) & (USD Million)
Table 127. Europe Immuno-oncology Therapy Consumption Value by Application (2019-2024) & (USD Million)
Table 128. Europe Immuno-oncology Therapy Consumption Value by Application (2025-2030) & (USD Million)
Table 129. Europe Immuno-oncology Therapy Consumption Value by Country (2019-2024) & (USD Million)
Table 130. Europe Immuno-oncology Therapy Consumption Value by Country (2025-2030) & (USD Million)
Table 131. Asia-Pacific Immuno-oncology Therapy Consumption Value by Type (2019-2024) & (USD Million)
Table 132. Asia-Pacific Immuno-oncology Therapy Consumption Value by Type (2025-2030) & (USD Million)
Table 133. Asia-Pacific Immuno-oncology Therapy Consumption Value by Application (2019-2024) & (USD Million)
Table 134. Asia-Pacific Immuno-oncology Therapy Consumption Value by Application (2025-2030) & (USD Million)
Table 135. Asia-Pacific Immuno-oncology Therapy Consumption Value by Region (2019-2024) & (USD Million)
Table 136. Asia-Pacific Immuno-oncology Therapy Consumption Value by Region (2025-2030) & (USD Million)
Table 137. South America Immuno-oncology Therapy Consumption Value by Type (2019-2024) & (USD Million)
Table 138. South America Immuno-oncology Therapy Consumption Value by Type (2025-2030) & (USD Million)
Table 139. South America Immuno-oncology Therapy Consumption Value by Application (2019-2024) & (USD Million)
Table 140. South America Immuno-oncology Therapy Consumption Value by Application (2025-2030) & (USD Million)
Table 141. South America Immuno-oncology Therapy Consumption Value by Country (2019-2024) & (USD Million)
Table 142. South America Immuno-oncology Therapy Consumption Value by Country (2025-2030) & (USD Million)
Table 143. Middle East & Africa Immuno-oncology Therapy Consumption Value by Type (2019-2024) & (USD Million)
Table 144. Middle East & Africa Immuno-oncology Therapy Consumption Value by Type (2025-2030) & (USD Million)
Table 145. Middle East & Africa Immuno-oncology Therapy Consumption Value by Application (2019-2024) & (USD Million)
Table 146. Middle East & Africa Immuno-oncology Therapy Consumption Value by Application (2025-2030) & (USD Million)
Table 147. Middle East & Africa Immuno-oncology Therapy Consumption Value by Country (2019-2024) & (USD Million)
Table 148. Middle East & Africa Immuno-oncology Therapy Consumption Value by Country (2025-2030) & (USD Million)
Table 149. Immuno-oncology Therapy Raw Material
Table 150. Key Suppliers of Immuno-oncology Therapy Raw Materials
Table 1. Global Immuno-oncology Therapy Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Immuno-oncology Therapy Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Immuno-oncology Therapy Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Immuno-oncology Therapy Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Amgen Company Information, Head Office, and Major Competitors
Table 6. Amgen Major Business
Table 7. Amgen Immuno-oncology Therapy Product and Solutions
Table 8. Amgen Immuno-oncology Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Amgen Recent Developments and Future Plans
Table 10. AstraZeneca Company Information, Head Office, and Major Competitors
Table 11. AstraZeneca Major Business
Table 12. AstraZeneca Immuno-oncology Therapy Product and Solutions
Table 13. AstraZeneca Immuno-oncology Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. AstraZeneca Recent Developments and Future Plans
Table 15. Bristol-Myers Squibb Company Information, Head Office, and Major Competitors
Table 16. Bristol-Myers Squibb Major Business
Table 17. Bristol-Myers Squibb Immuno-oncology Therapy Product and Solutions
Table 18. Bristol-Myers Squibb Immuno-oncology Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Bristol-Myers Squibb Recent Developments and Future Plans
Table 20. Eli-Lilly Company Information, Head Office, and Major Competitors
Table 21. Eli-Lilly Major Business
Table 22. Eli-Lilly Immuno-oncology Therapy Product and Solutions
Table 23. Eli-Lilly Immuno-oncology Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Eli-Lilly Recent Developments and Future Plans
Table 25. Roche Company Information, Head Office, and Major Competitors
Table 26. Roche Major Business
Table 27. Roche Immuno-oncology Therapy Product and Solutions
Table 28. Roche Immuno-oncology Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Roche Recent Developments and Future Plans
Table 30. GlaxoSmithKline Company Information, Head Office, and Major Competitors
Table 31. GlaxoSmithKline Major Business
Table 32. GlaxoSmithKline Immuno-oncology Therapy Product and Solutions
Table 33. GlaxoSmithKline Immuno-oncology Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. GlaxoSmithKline Recent Developments and Future Plans
Table 35. Janssen Biotech Company Information, Head Office, and Major Competitors
Table 36. Janssen Biotech Major Business
Table 37. Janssen Biotech Immuno-oncology Therapy Product and Solutions
Table 38. Janssen Biotech Immuno-oncology Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Janssen Biotech Recent Developments and Future Plans
Table 40. Merck Company Information, Head Office, and Major Competitors
Table 41. Merck Major Business
Table 42. Merck Immuno-oncology Therapy Product and Solutions
Table 43. Merck Immuno-oncology Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Merck Recent Developments and Future Plans
Table 45. Novartis Company Information, Head Office, and Major Competitors
Table 46. Novartis Major Business
Table 47. Novartis Immuno-oncology Therapy Product and Solutions
Table 48. Novartis Immuno-oncology Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Novartis Recent Developments and Future Plans
Table 50. Pfizer Company Information, Head Office, and Major Competitors
Table 51. Pfizer Major Business
Table 52. Pfizer Immuno-oncology Therapy Product and Solutions
Table 53. Pfizer Immuno-oncology Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Pfizer Recent Developments and Future Plans
Table 55. Sanofi Company Information, Head Office, and Major Competitors
Table 56. Sanofi Major Business
Table 57. Sanofi Immuno-oncology Therapy Product and Solutions
Table 58. Sanofi Immuno-oncology Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. Sanofi Recent Developments and Future Plans
Table 60. Spectrum Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 61. Spectrum Pharmaceuticals Major Business
Table 62. Spectrum Pharmaceuticals Immuno-oncology Therapy Product and Solutions
Table 63. Spectrum Pharmaceuticals Immuno-oncology Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. Spectrum Pharmaceuticals Recent Developments and Future Plans
Table 65. Takeda Company Information, Head Office, and Major Competitors
Table 66. Takeda Major Business
Table 67. Takeda Immuno-oncology Therapy Product and Solutions
Table 68. Takeda Immuno-oncology Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. Takeda Recent Developments and Future Plans
Table 70. BioNTech SE Company Information, Head Office, and Major Competitors
Table 71. BioNTech SE Major Business
Table 72. BioNTech SE Immuno-oncology Therapy Product and Solutions
Table 73. BioNTech SE Immuno-oncology Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 74. BioNTech SE Recent Developments and Future Plans
Table 75. Allogene Therapeutics Company Information, Head Office, and Major Competitors
Table 76. Allogene Therapeutics Major Business
Table 77. Allogene Therapeutics Immuno-oncology Therapy Product and Solutions
Table 78. Allogene Therapeutics Immuno-oncology Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 79. Allogene Therapeutics Recent Developments and Future Plans
Table 80. IMAB-I-Mab Biopharma Co., Ltd. Company Information, Head Office, and Major Competitors
Table 81. IMAB-I-Mab Biopharma Co., Ltd. Major Business
Table 82. IMAB-I-Mab Biopharma Co., Ltd. Immuno-oncology Therapy Product and Solutions
Table 83. IMAB-I-Mab Biopharma Co., Ltd. Immuno-oncology Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 84. IMAB-I-Mab Biopharma Co., Ltd. Recent Developments and Future Plans
Table 85. Arcus Biosciences Company Information, Head Office, and Major Competitors
Table 86. Arcus Biosciences Major Business
Table 87. Arcus Biosciences Immuno-oncology Therapy Product and Solutions
Table 88. Arcus Biosciences Immuno-oncology Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Arcus Biosciences Recent Developments and Future Plans
Table 90. Gritstone Oncology Company Information, Head Office, and Major Competitors
Table 91. Gritstone Oncology Major Business
Table 92. Gritstone Oncology Immuno-oncology Therapy Product and Solutions
Table 93. Gritstone Oncology Immuno-oncology Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 94. Gritstone Oncology Recent Developments and Future Plans
Table 95. Autolus Therapeutics Company Information, Head Office, and Major Competitors
Table 96. Autolus Therapeutics Major Business
Table 97. Autolus Therapeutics Immuno-oncology Therapy Product and Solutions
Table 98. Autolus Therapeutics Immuno-oncology Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 99. Autolus Therapeutics Recent Developments and Future Plans
Table 100. Rubius Therapeutics Company Information, Head Office, and Major Competitors
Table 101. Rubius Therapeutics Major Business
Table 102. Rubius Therapeutics Immuno-oncology Therapy Product and Solutions
Table 103. Rubius Therapeutics Immuno-oncology Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 104. Rubius Therapeutics Recent Developments and Future Plans
Table 105. Global Immuno-oncology Therapy Revenue (USD Million) by Players (2019-2024)
Table 106. Global Immuno-oncology Therapy Revenue Share by Players (2019-2024)
Table 107. Breakdown of Immuno-oncology Therapy by Company Type (Tier 1, Tier 2, and Tier 3)
Table 108. Market Position of Players in Immuno-oncology Therapy, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 109. Head Office of Key Immuno-oncology Therapy Players
Table 110. Immuno-oncology Therapy Market: Company Product Type Footprint
Table 111. Immuno-oncology Therapy Market: Company Product Application Footprint
Table 112. Immuno-oncology Therapy New Market Entrants and Barriers to Market Entry
Table 113. Immuno-oncology Therapy Mergers, Acquisition, Agreements, and Collaborations
Table 114. Global Immuno-oncology Therapy Consumption Value (USD Million) by Type (2019-2024)
Table 115. Global Immuno-oncology Therapy Consumption Value Share by Type (2019-2024)
Table 116. Global Immuno-oncology Therapy Consumption Value Forecast by Type (2025-2030)
Table 117. Global Immuno-oncology Therapy Consumption Value by Application (2019-2024)
Table 118. Global Immuno-oncology Therapy Consumption Value Forecast by Application (2025-2030)
Table 119. North America Immuno-oncology Therapy Consumption Value by Type (2019-2024) & (USD Million)
Table 120. North America Immuno-oncology Therapy Consumption Value by Type (2025-2030) & (USD Million)
Table 121. North America Immuno-oncology Therapy Consumption Value by Application (2019-2024) & (USD Million)
Table 122. North America Immuno-oncology Therapy Consumption Value by Application (2025-2030) & (USD Million)
Table 123. North America Immuno-oncology Therapy Consumption Value by Country (2019-2024) & (USD Million)
Table 124. North America Immuno-oncology Therapy Consumption Value by Country (2025-2030) & (USD Million)
Table 125. Europe Immuno-oncology Therapy Consumption Value by Type (2019-2024) & (USD Million)
Table 126. Europe Immuno-oncology Therapy Consumption Value by Type (2025-2030) & (USD Million)
Table 127. Europe Immuno-oncology Therapy Consumption Value by Application (2019-2024) & (USD Million)
Table 128. Europe Immuno-oncology Therapy Consumption Value by Application (2025-2030) & (USD Million)
Table 129. Europe Immuno-oncology Therapy Consumption Value by Country (2019-2024) & (USD Million)
Table 130. Europe Immuno-oncology Therapy Consumption Value by Country (2025-2030) & (USD Million)
Table 131. Asia-Pacific Immuno-oncology Therapy Consumption Value by Type (2019-2024) & (USD Million)
Table 132. Asia-Pacific Immuno-oncology Therapy Consumption Value by Type (2025-2030) & (USD Million)
Table 133. Asia-Pacific Immuno-oncology Therapy Consumption Value by Application (2019-2024) & (USD Million)
Table 134. Asia-Pacific Immuno-oncology Therapy Consumption Value by Application (2025-2030) & (USD Million)
Table 135. Asia-Pacific Immuno-oncology Therapy Consumption Value by Region (2019-2024) & (USD Million)
Table 136. Asia-Pacific Immuno-oncology Therapy Consumption Value by Region (2025-2030) & (USD Million)
Table 137. South America Immuno-oncology Therapy Consumption Value by Type (2019-2024) & (USD Million)
Table 138. South America Immuno-oncology Therapy Consumption Value by Type (2025-2030) & (USD Million)
Table 139. South America Immuno-oncology Therapy Consumption Value by Application (2019-2024) & (USD Million)
Table 140. South America Immuno-oncology Therapy Consumption Value by Application (2025-2030) & (USD Million)
Table 141. South America Immuno-oncology Therapy Consumption Value by Country (2019-2024) & (USD Million)
Table 142. South America Immuno-oncology Therapy Consumption Value by Country (2025-2030) & (USD Million)
Table 143. Middle East & Africa Immuno-oncology Therapy Consumption Value by Type (2019-2024) & (USD Million)
Table 144. Middle East & Africa Immuno-oncology Therapy Consumption Value by Type (2025-2030) & (USD Million)
Table 145. Middle East & Africa Immuno-oncology Therapy Consumption Value by Application (2019-2024) & (USD Million)
Table 146. Middle East & Africa Immuno-oncology Therapy Consumption Value by Application (2025-2030) & (USD Million)
Table 147. Middle East & Africa Immuno-oncology Therapy Consumption Value by Country (2019-2024) & (USD Million)
Table 148. Middle East & Africa Immuno-oncology Therapy Consumption Value by Country (2025-2030) & (USD Million)
Table 149. Immuno-oncology Therapy Raw Material
Table 150. Key Suppliers of Immuno-oncology Therapy Raw Materials
LIST OF FIGURES
Figure 1. Immuno-oncology Therapy Picture
Figure 2. Global Immuno-oncology Therapy Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Immuno-oncology Therapy Consumption Value Market Share by Type in 2023
Figure 4. Monoclonal Antibodies
Figure 5. Immune Checkpoint Inhibitors
Figure 6. Immune System Modulators
Figure 7. Cancer Vaccines
Figure 8. Global Immuno-oncology Therapy Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 9. Immuno-oncology Therapy Consumption Value Market Share by Application in 2023
Figure 10. Hospitals Picture
Figure 11. Ambulatory Surgical Center Picture
Figure 12. Others Picture
Figure 13. Global Immuno-oncology Therapy Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 14. Global Immuno-oncology Therapy Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 15. Global Market Immuno-oncology Therapy Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 16. Global Immuno-oncology Therapy Consumption Value Market Share by Region (2019-2030)
Figure 17. Global Immuno-oncology Therapy Consumption Value Market Share by Region in 2023
Figure 18. North America Immuno-oncology Therapy Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe Immuno-oncology Therapy Consumption Value (2019-2030) & (USD Million)
Figure 20. Asia-Pacific Immuno-oncology Therapy Consumption Value (2019-2030) & (USD Million)
Figure 21. South America Immuno-oncology Therapy Consumption Value (2019-2030) & (USD Million)
Figure 22. Middle East and Africa Immuno-oncology Therapy Consumption Value (2019-2030) & (USD Million)
Figure 23. Global Immuno-oncology Therapy Revenue Share by Players in 2023
Figure 24. Immuno-oncology Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 25. Global Top 3 Players Immuno-oncology Therapy Market Share in 2023
Figure 26. Global Top 6 Players Immuno-oncology Therapy Market Share in 2023
Figure 27. Global Immuno-oncology Therapy Consumption Value Share by Type (2019-2024)
Figure 28. Global Immuno-oncology Therapy Market Share Forecast by Type (2025-2030)
Figure 29. Global Immuno-oncology Therapy Consumption Value Share by Application (2019-2024)
Figure 30. Global Immuno-oncology Therapy Market Share Forecast by Application (2025-2030)
Figure 31. North America Immuno-oncology Therapy Consumption Value Market Share by Type (2019-2030)
Figure 32. North America Immuno-oncology Therapy Consumption Value Market Share by Application (2019-2030)
Figure 33. North America Immuno-oncology Therapy Consumption Value Market Share by Country (2019-2030)
Figure 34. United States Immuno-oncology Therapy Consumption Value (2019-2030) & (USD Million)
Figure 35. Canada Immuno-oncology Therapy Consumption Value (2019-2030) & (USD Million)
Figure 36. Mexico Immuno-oncology Therapy Consumption Value (2019-2030) & (USD Million)
Figure 37. Europe Immuno-oncology Therapy Consumption Value Market Share by Type (2019-2030)
Figure 38. Europe Immuno-oncology Therapy Consumption Value Market Share by Application (2019-2030)
Figure 39. Europe Immuno-oncology Therapy Consumption Value Market Share by Country (2019-2030)
Figure 40. Germany Immuno-oncology Therapy Consumption Value (2019-2030) & (USD Million)
Figure 41. France Immuno-oncology Therapy Consumption Value (2019-2030) & (USD Million)
Figure 42. United Kingdom Immuno-oncology Therapy Consumption Value (2019-2030) & (USD Million)
Figure 43. Russia Immuno-oncology Therapy Consumption Value (2019-2030) & (USD Million)
Figure 44. Italy Immuno-oncology Therapy Consumption Value (2019-2030) & (USD Million)
Figure 45. Asia-Pacific Immuno-oncology Therapy Consumption Value Market Share by Type (2019-2030)
Figure 46. Asia-Pacific Immuno-oncology Therapy Consumption Value Market Share by Application (2019-2030)
Figure 47. Asia-Pacific Immuno-oncology Therapy Consumption Value Market Share by Region (2019-2030)
Figure 48. China Immuno-oncology Therapy Consumption Value (2019-2030) & (USD Million)
Figure 49. Japan Immuno-oncology Therapy Consumption Value (2019-2030) & (USD Million)
Figure 50. South Korea Immuno-oncology Therapy Consumption Value (2019-2030) & (USD Million)
Figure 51. India Immuno-oncology Therapy Consumption Value (2019-2030) & (USD Million)
Figure 52. Southeast Asia Immuno-oncology Therapy Consumption Value (2019-2030) & (USD Million)
Figure 53. Australia Immuno-oncology Therapy Consumption Value (2019-2030) & (USD Million)
Figure 54. South America Immuno-oncology Therapy Consumption Value Market Share by Type (2019-2030)
Figure 55. South America Immuno-oncology Therapy Consumption Value Market Share by Application (2019-2030)
Figure 56. South America Immuno-oncology Therapy Consumption Value Market Share by Country (2019-2030)
Figure 57. Brazil Immuno-oncology Therapy Consumption Value (2019-2030) & (USD Million)
Figure 58. Argentina Immuno-oncology Therapy Consumption Value (2019-2030) & (USD Million)
Figure 59. Middle East and Africa Immuno-oncology Therapy Consumption Value Market Share by Type (2019-2030)
Figure 60. Middle East and Africa Immuno-oncology Therapy Consumption Value Market Share by Application (2019-2030)
Figure 61. Middle East and Africa Immuno-oncology Therapy Consumption Value Market Share by Country (2019-2030)
Figure 62. Turkey Immuno-oncology Therapy Consumption Value (2019-2030) & (USD Million)
Figure 63. Saudi Arabia Immuno-oncology Therapy Consumption Value (2019-2030) & (USD Million)
Figure 64. UAE Immuno-oncology Therapy Consumption Value (2019-2030) & (USD Million)
Figure 65. Immuno-oncology Therapy Market Drivers
Figure 66. Immuno-oncology Therapy Market Restraints
Figure 67. Immuno-oncology Therapy Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Manufacturing Cost Structure Analysis of Immuno-oncology Therapy in 2023
Figure 70. Manufacturing Process Analysis of Immuno-oncology Therapy
Figure 71. Immuno-oncology Therapy Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
Figure 1. Immuno-oncology Therapy Picture
Figure 2. Global Immuno-oncology Therapy Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Immuno-oncology Therapy Consumption Value Market Share by Type in 2023
Figure 4. Monoclonal Antibodies
Figure 5. Immune Checkpoint Inhibitors
Figure 6. Immune System Modulators
Figure 7. Cancer Vaccines
Figure 8. Global Immuno-oncology Therapy Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 9. Immuno-oncology Therapy Consumption Value Market Share by Application in 2023
Figure 10. Hospitals Picture
Figure 11. Ambulatory Surgical Center Picture
Figure 12. Others Picture
Figure 13. Global Immuno-oncology Therapy Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 14. Global Immuno-oncology Therapy Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 15. Global Market Immuno-oncology Therapy Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 16. Global Immuno-oncology Therapy Consumption Value Market Share by Region (2019-2030)
Figure 17. Global Immuno-oncology Therapy Consumption Value Market Share by Region in 2023
Figure 18. North America Immuno-oncology Therapy Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe Immuno-oncology Therapy Consumption Value (2019-2030) & (USD Million)
Figure 20. Asia-Pacific Immuno-oncology Therapy Consumption Value (2019-2030) & (USD Million)
Figure 21. South America Immuno-oncology Therapy Consumption Value (2019-2030) & (USD Million)
Figure 22. Middle East and Africa Immuno-oncology Therapy Consumption Value (2019-2030) & (USD Million)
Figure 23. Global Immuno-oncology Therapy Revenue Share by Players in 2023
Figure 24. Immuno-oncology Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 25. Global Top 3 Players Immuno-oncology Therapy Market Share in 2023
Figure 26. Global Top 6 Players Immuno-oncology Therapy Market Share in 2023
Figure 27. Global Immuno-oncology Therapy Consumption Value Share by Type (2019-2024)
Figure 28. Global Immuno-oncology Therapy Market Share Forecast by Type (2025-2030)
Figure 29. Global Immuno-oncology Therapy Consumption Value Share by Application (2019-2024)
Figure 30. Global Immuno-oncology Therapy Market Share Forecast by Application (2025-2030)
Figure 31. North America Immuno-oncology Therapy Consumption Value Market Share by Type (2019-2030)
Figure 32. North America Immuno-oncology Therapy Consumption Value Market Share by Application (2019-2030)
Figure 33. North America Immuno-oncology Therapy Consumption Value Market Share by Country (2019-2030)
Figure 34. United States Immuno-oncology Therapy Consumption Value (2019-2030) & (USD Million)
Figure 35. Canada Immuno-oncology Therapy Consumption Value (2019-2030) & (USD Million)
Figure 36. Mexico Immuno-oncology Therapy Consumption Value (2019-2030) & (USD Million)
Figure 37. Europe Immuno-oncology Therapy Consumption Value Market Share by Type (2019-2030)
Figure 38. Europe Immuno-oncology Therapy Consumption Value Market Share by Application (2019-2030)
Figure 39. Europe Immuno-oncology Therapy Consumption Value Market Share by Country (2019-2030)
Figure 40. Germany Immuno-oncology Therapy Consumption Value (2019-2030) & (USD Million)
Figure 41. France Immuno-oncology Therapy Consumption Value (2019-2030) & (USD Million)
Figure 42. United Kingdom Immuno-oncology Therapy Consumption Value (2019-2030) & (USD Million)
Figure 43. Russia Immuno-oncology Therapy Consumption Value (2019-2030) & (USD Million)
Figure 44. Italy Immuno-oncology Therapy Consumption Value (2019-2030) & (USD Million)
Figure 45. Asia-Pacific Immuno-oncology Therapy Consumption Value Market Share by Type (2019-2030)
Figure 46. Asia-Pacific Immuno-oncology Therapy Consumption Value Market Share by Application (2019-2030)
Figure 47. Asia-Pacific Immuno-oncology Therapy Consumption Value Market Share by Region (2019-2030)
Figure 48. China Immuno-oncology Therapy Consumption Value (2019-2030) & (USD Million)
Figure 49. Japan Immuno-oncology Therapy Consumption Value (2019-2030) & (USD Million)
Figure 50. South Korea Immuno-oncology Therapy Consumption Value (2019-2030) & (USD Million)
Figure 51. India Immuno-oncology Therapy Consumption Value (2019-2030) & (USD Million)
Figure 52. Southeast Asia Immuno-oncology Therapy Consumption Value (2019-2030) & (USD Million)
Figure 53. Australia Immuno-oncology Therapy Consumption Value (2019-2030) & (USD Million)
Figure 54. South America Immuno-oncology Therapy Consumption Value Market Share by Type (2019-2030)
Figure 55. South America Immuno-oncology Therapy Consumption Value Market Share by Application (2019-2030)
Figure 56. South America Immuno-oncology Therapy Consumption Value Market Share by Country (2019-2030)
Figure 57. Brazil Immuno-oncology Therapy Consumption Value (2019-2030) & (USD Million)
Figure 58. Argentina Immuno-oncology Therapy Consumption Value (2019-2030) & (USD Million)
Figure 59. Middle East and Africa Immuno-oncology Therapy Consumption Value Market Share by Type (2019-2030)
Figure 60. Middle East and Africa Immuno-oncology Therapy Consumption Value Market Share by Application (2019-2030)
Figure 61. Middle East and Africa Immuno-oncology Therapy Consumption Value Market Share by Country (2019-2030)
Figure 62. Turkey Immuno-oncology Therapy Consumption Value (2019-2030) & (USD Million)
Figure 63. Saudi Arabia Immuno-oncology Therapy Consumption Value (2019-2030) & (USD Million)
Figure 64. UAE Immuno-oncology Therapy Consumption Value (2019-2030) & (USD Million)
Figure 65. Immuno-oncology Therapy Market Drivers
Figure 66. Immuno-oncology Therapy Market Restraints
Figure 67. Immuno-oncology Therapy Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Manufacturing Cost Structure Analysis of Immuno-oncology Therapy in 2023
Figure 70. Manufacturing Process Analysis of Immuno-oncology Therapy
Figure 71. Immuno-oncology Therapy Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
